In the few cases where ECM components have been targeted before, target proteins such as tumour‐specific variants of the ECM proteins fibronectin and tenascin are primarily located around tumour blood vessels (Borsi et al, 2003; Kim et al, 2012). The gene discussed is FN1; the disease is neoplasm.